Avadel Pharmaceuticals plc (AVDL) insider trading
Every open-market stock purchase and sale by Avadel Pharmaceuticals plc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $233M over the last 12 months (1 sale). No open-market buys.
- Last insider buy: Linda Palczuk (Director), $39.6K, 20 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $233M (1 sale).
Recent AVDL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Feb 13, 2026 | Weiss Asset Management LP (Insider) | Sold | $233M |
| Feb 12, 2026 | Gregory J Divis (CEO) | Sold (not open market) | $8.1M |
| Feb 12, 2026 | Eric J Ende (Director) | Sold (not open market) | $4.6M |
| Feb 12, 2026 | Gregory J Divis (CEO) | Sold (not open market) | $4.4M |
| Feb 12, 2026 | Gregory J Divis (CEO) | Sold (not open market) | $3.4M |
| Feb 12, 2026 | Susan Rodriguez (COO) | Sold (not open market) | $2.9M |
| Feb 12, 2026 | Gregory J Divis (CEO) | Sold (not open market) | $2.4M |
| Feb 12, 2026 | Peter J. Thornton (Director) | Sold (not open market) | $2.4M |
| Feb 12, 2026 | Thomas S McHugh (CFO) | Sold (not open market) | $2.1M |
| Feb 12, 2026 | Thomas S McHugh (CFO) | Sold (not open market) | $2.1M |
| Feb 12, 2026 | Jerad G. Seurer (Officer) | Sold (not open market) | $1.7M |
| Feb 12, 2026 | Linda Palczuk (Director) | Sold (not open market) | $1.7M |
| Feb 12, 2026 | Gregory J Divis (CEO) | Sold (not open market) | $1.6M |
| Feb 12, 2026 | Geoffrey Michael Glass (Director) | Sold (not open market) | $1.6M |
| Feb 12, 2026 | Gregory J Divis (CEO) | Sold (not open market) | $1.6M |
| Feb 12, 2026 | Geoffrey Michael Glass (Director) | Sold (not open market) | $1.5M |
| Feb 12, 2026 | Mark Anthony McCamish (Director) | Sold (not open market) | $1.4M |
| Feb 12, 2026 | Thomas S McHugh (CFO) | Sold (not open market) | $1.4M |
| Feb 12, 2026 | Thomas S McHugh (CFO) | Sold (not open market) | $1.2M |
| Feb 12, 2026 | Thomas S McHugh (CFO) | Sold (not open market) | $863K |
| Feb 12, 2026 | Thomas S McHugh (CFO) | Sold (not open market) | $821K |
| Feb 12, 2026 | Naseem Amin (Director) | Sold (not open market) | $789K |
| Feb 12, 2026 | Gregory J Divis (CEO) | Sold (not open market) | $684K |
| Feb 12, 2026 | Jerad G. Seurer (Officer) | Sold (not open market) | $661K |
| Feb 12, 2026 | Thomas S McHugh (CFO) | Sold (not open market) | $567K |
Who's trading AVDL
- Weiss Asset Management LP, Insider: sold $233M (1 sale), last Feb 13, 2026
- Gregory J Divis, CEO: other filings, last Feb 12, 2026
- Eric J Ende, Director: other filings, last Feb 12, 2026
- Geoffrey Michael Glass, Director: other filings, last Feb 12, 2026
- Thomas S McHugh, CFO: other filings, last Feb 12, 2026
- Naseem Amin, Director: other filings, last Feb 12, 2026
- Linda Palczuk, Director: other filings, last Feb 12, 2026
- Susan Rodriguez, COO: other filings, last Feb 12, 2026
- Jerad G. Seurer, Officer: other filings, last Feb 12, 2026
- Peter J. Thornton, Director: other filings, last Feb 12, 2026
- Mark Anthony McCamish, Director: other filings, last Feb 12, 2026
Get free alerts when an insider at Avadel Pharmaceuticals plc files a new trade →